Theragen Molecular Innovation Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
About Theragen Molecular Innovation
Theragen Molecular Innovation Private Limited (TMIPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 December 2020 (Four years and two months 9 days old ). Its registered office is in Kanchipuram, Tamil Nadu, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Arumugam Sivaraman, Andal Arumugam, and Chaniyilparampu Ramchand serve as directors at the Company.
Company Details
- Location
Kanchipuram, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U73100TN2020PTC140124
- Company No.
140124
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Dec 2020
- Date of AGM
26 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Theragen Molecular Innovation?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arumugam Sivaraman  | Director | 15-Dec-2020 | Current |
| Andal Arumugam | Director | 15-Dec-2020 | Current |
Chaniyilparampu Ramchand  | Director | 15-Dec-2020 | Current |
Financial Performance of Theragen Molecular Innovation.
Theragen Molecular Innovation Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Theragen Molecular Innovation?
In 2021, Theragen Molecular Innovation had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sri Ramachandra Sports Sciences Private LimitedArumugam Sivaraman and Andal Arumugam are mutual person
Axon Constructions Private LimitedArumugam Sivaraman is a mutual person
Maggenome Technologies Private LimitedArumugam Sivaraman and Chaniyilparampu Ramchand are mutual person
Tcp LimitedChaniyilparampu Ramchand is a mutual person
Bbp Studio Virtual Bharat Private LimitedArumugam Sivaraman is a mutual person
R.K.Powergen Private LimitedArumugam Sivaraman and Andal Arumugam are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Theragen Molecular Innovation?
Theragen Molecular Innovation has a workforce of 1 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Theragen Molecular Innovation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Theragen Molecular Innovation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.